Replimune Group Inc

REPL NASDAQ Santé & Biotech États-Unis US76029N1063
10.12 $
1.40 %

Replimune Group Inc est une entreprise biotechnologique concentrée sur le développement de thérapies oncolytiques destinées au traitement du cancer.

Performance & Momentum

6 Months 4.44 %
1 Year 6.64 %
3 Years 57.21 %
5 Years 71.41 %

Similar stocks to Replimune Group Inc

Anantys Community

Be the first to share your analysis on Replimune Group Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases